INSIGHTS ON SOLID DOSE MANUFACTURING

• How To Address Your Solid Dosage Processing Needs

  Unlock the keys to consistent solid dosage products. Learn to align unique product needs with optimal processing requirements and equipment strategies. Gain a roadmap for improved quality and reproducibility.

• Cytiva's Aseptic Filling Workcell User Group

  Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.

• High Potency APIs And The Evolving Demands Of Drug Development

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

• Automated Precision Powder Filling For Annex 1

  Aseptic powder filling is complex, demanding automation and isolator‑based, weight‑controlled dosing to ensure sterility and accuracy.

• Navigating High-Potency OSD Manufacturing

  4/13/2026

  Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.

• How To Handle Intrinsic Product Powder Particles

  3/16/2026

  Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.

• The Importance Of Polymorph Screenings

  5/6/2026

  Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

• Minitablets: Enhancing Safety And Palatability For Pediatric Medicines

  1/15/2026

  Leverage minitablet technology to create flexible, easy-to-swallow, and palatable pediatric formulations that improve adherence and meet evolving regulatory requirements.

• The Future Of Oral Solid Dose Development And Innovation

  2/27/2025

  Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.